ClinicalTrials.gg
CompletedNCT07419737Updated Feb 19, 2026

Dental Plaque Prevention Efficacy of a Stannous Fluoride Toothpaste

An interventional study of Stannous Fluoride Toothpaste (SnF) and Sodium Fluoride Dentifrice in Dental Plaque, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Church & Dwight Company, Inc. · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Oct 2024, registered Feb 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Ages
18 Years to 69 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 65 studies in Dental Plaque with a site in United States — 7 open to participants now, 8 under way, 1 of them phase 3. Dental Plaque · United States.

Enrollment
22nd of 59
91 · median 80
Started
2024
with 4 others
No phase
33 of 65
6 open now
Registered
57th of 65
by date
Lead sponsor
2 of 65
Church & Dwight Company, Inc.

Among the 65 studies in Dental Plaque with a site in United States, this one is the 22nd largest by enrollment of the 59 interventional ones that give a count, is one of 5 that started in 2024, is one of 33 with no phase, and was the 57th registered.

Dental Plaque

352 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.

Browse Dental Plaque studies →

Open to participants now

7 of the 65 studies in Dental Plaque with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.

This study: 18 Years to 69 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Dental Plaque with a site in United States, or all of them as a file.
02

Study summary

This randomized, stratified, double-blind, two-cell parallel clinical study evaluated the dental plaque prevention efficacy of a stannous fluoride toothpaste compared to a sodium fluoride control toothpaste following a professional dental prophylaxis. Adult subjects brushed twice daily for 14 days with their assigned dentifrice. Plaque was assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index at baseline, Day 1, and Day 14 following periods of oral hygiene abstention.

Read the detailed description

This two-week, randomized, double-blind, parallel-group study evaluated plaque prevention following dental cleaning. Subjects meeting plaque qualification criteria underwent a complete prophylaxis and were randomized to either a stannous fluoride test dentifrice or a sodium fluoride control dentifrice. Subjects brushed twice daily for two minutes with the assigned product. Plaque accumulation was assessed at baseline, after one day of use, and after 14 days of use following overnight abstention from oral hygiene. Plaque was disclosed and scored on facial and lingual tooth surfaces using the Lobene-Soparkar modified Turesky Plaque Index. Treatment comparisons were performed using ANCOVA with baseline plaque as a covariate.

03

Conditions studied

  • Dental Plaque

Browse trials for

04

Who can participate

Ages eligible
18 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Good general health based on medical history
  • Minimum of 18 natural teeth with scorable surfaces
  • Baseline mean plaque score ≥2.0
  • Willing to refrain from non-study oral hygiene products
  • Willing to abstain from oral hygiene prior to study visits
  • Able and willing to comply with study procedures

Exclusion criteria

Exclusion Criteria:

  • Known allergy to oral care products
  • Conditions limiting normal brushing
  • Significant medical conditions affecting study participation
  • Pregnant or nursing females
  • Severe periodontal disease
  • Recent dental prophylaxis
  • Recent participation in another dental study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
91 participants (actual)

Study arms

  • Other
    Sodium Fluoride Control Dentifrice

    Dentifrice containing sodium fluoride, serving as the control comparator.

    Drug: Sodium Fluoride Dentifrice

  • Experimental
    Stannous Fluoride Toothpaste

    Dentifrice containing stannous fluoride evaluated for plaque prevention compared to sodium fluoride control.

    Drug: Stannous Fluoride Toothpaste (SnF)

Interventions

06

What researchers measure

Primary outcomes

  1. Whole-Mouth Dental Plaque Score (Turesky Modified Quigley-Hein Index)

    Mean whole-mouth plaque index score assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index. Treatment comparisons performed using ANCOVA with baseline plaque score as a covariate.

    Time frame: Day 14 (12 hours post-brushing following 14 days of twice-daily use)

Secondary outcomes

  1. Whole-Mouth Dental Plaque Score at Day 1

    Mean whole-mouth plaque index score assessed one day after initial supervised brushing.

    Time frame: Day 1 (12 hours post-brushing)

07

Study locations

1 site
  • Salus Research, Inc.
    Fort Wayne, Indiana 46825, United States
08

References and documents

Individual participant data

Plan to share: No — The sponsor does not plan to share individual participant data. Summary results will be provided as required, but no de-identified datasets will be made publicly available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Dec 2024, 1 month.

Of 45 industry-sponsored interventional studies with no phase under Dental Plaque, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 8. This study's 1 month is below that.

Counting every sponsor, half of 178 studies reached it within 6 months; a quarter within 2 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Feb 19, 2026
StartActual
Oct 16, 2024
Primary completionActual
Dec 4, 2024
CompletionActual
Dec 4, 2024
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07419737
Responsible party
Sponsor
First posted
Feb 19, 2026
Start date
Oct 16, 2024
Primary completion
Dec 4, 2024
Completion
Dec 4, 2024
Last update
Feb 19, 2026

Study contacts

Annahita Ghassemi, PhD
study director · Church & Dwight, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion